[1] |
SUNG H, FERLAY J, SIEGEL R L,et al. Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3):209-249. DOI: 10.3322/caac.21660.
|
[2] |
|
[3] |
SAKAI M, KITAGAWA Y, SAEKI H,et al. Fruit and vegetable consumption and risk of esophageal cancer in the Asian region:a systematic review and meta-analysis[J]. Esophagus, 2022, 19(1):27-38. DOI: 10.1007/s10388-021-00882-6.
|
[4] |
CHEN Y, HUANG K N, DING X Y,et al. Magnolol inhibits growth and induces apoptosis in esophagus cancer KYSE-150 cell lines via the MAP kinase pathway[J]. J Thorac Dis, 2019, 11(7):3030-3038. DOI: 10.21037/jtd.2019.07.46.
|
[5] |
LV J, JIA Y T, LI J,et al. Gegen Qinlian Decoction enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by remodelling the gut microbiota and the tumour microenvironment[J]. Cell Death Dis, 2019, 10(6):415. DOI: 10.1038/s41419-019-1638-6.
|
[6] |
EUN C S, KIM B K, HAN D S,et al. Differences in gastric mucosal microbiota profiling in patients with chronic gastritis,intestinal metaplasia,and gastric cancer using pyrosequencing methods[J]. Helicobacter, 2014, 19(6):407-416. DOI: 10.1111/hel.12145.
|
[7] |
MA C, HAN M J, HEINRICH B,et al. Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells[J]. Science, 2018, 360(6391):eaan5931. DOI: 10.1126/science.aan5931.
|
[8] |
ROUTY B, LE CHATELIER E, DEROSA L,et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors[J]. Science, 2018, 359(6371):91-97. DOI: 10.1126/science.aan3706.
|
[9] |
GOPALAKRISHNAN V, SPENCER C N, NEZI L,et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients[J]. Science, 2018, 359(6371):97-103. DOI: 10.1126/science.aan4236.
|
[10] |
中国临床肿瘤学会指南工作委员会组织. 中国临床肿瘤学会(CSCO)食管癌诊疗指南-2022[M]. 北京:人民卫生出版社,2022:10-42.
|
[11] |
ZHANG X Y, ZHAO S W, SONG X B,et al. Inhibition effect of glycyrrhiza polysaccharide(GCP)on tumor growth through regulation of the gut microbiota composition[J]. J Pharmacol Sci, 2018, 137(4):324-332. DOI: 10.1016/j.jphs.2018.03.006.
|
[12] |
MENG C T, BAI C M, BROWN T D,et al. Human gut microbiota and gastrointestinal cancer[J]. Genomics Proteomics Bioinformatics, 2018, 16(1):33-49. DOI: 10.1016/j.gpb.2017.06.002.
|
[13] |
|
[14] |
MA J, SUN L Q, LIU Y,et al. Alter between gut bacteria and blood metabolites and the anti-tumor effects of Faecalibacterium prausnitzii in breast cancer[J]. BMC Microbiol, 2020, 20(1):82. DOI: 10.1186/s12866-020-01739-1.
|
[15] |
GOPALAKRISHNAN V, SPENCER C N, NEZI L,et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients[J]. Science, 2018, 359(6371):97-103. DOI: 10.1126/science.aan4236.
|
[16] |
FONSECA-SILVA T, OLIVEIRA M V, FRAGA C A,et al. DNMT3B(C46359T)polymorphisms and immunoexpression of DNMT3b and DNMT1 proteins in oral lichen planus[J]. Pathobiology, 2012, 79(1):18-23. DOI: 10.1159/000330171.
|
[17] |
HEINKEN A, KHAN M T, PAGLIA G,et al. Functional metabolic map of Faecalibacterium prausnitzii,a beneficial human gut microbe[J]. J Bacteriol, 2014, 196(18):3289-3302. DOI: 10.1128/JB.01780-14.
|
[18] |
LOPEZ-SILES M, MARTINEZ-MEDINA M, SURÍS-VALLS R,et al. Changes in the abundance of faecalibacterium prausnitzii phylogroupsⅠ andⅡ in the intestinal mucosa of inflammatory bowel disease and patients with colorectal cancer[J]. Inflamm Bowel Dis, 2016, 22(1):28-41. DOI: 10.1097/MIB.0000000000000590.
|
[19] |
|
[20] |
ZHANG Z C, CAO H Y, SONG N,et al. Long-term hexavalent chromium exposure facilitates colorectal cancer in mice associated with changes in gut microbiota composition[J]. Food Chem Toxicol, 2020, 138:111237. DOI: 10.1016/j.fct.2020.111237.
|
[21] |
SEOL M, LEE Y R, KIM K M,et al. The difference of the gut microbiota of gastric cancer in relation to Helicobacter pylori negativity and positivity[J]. J Clin Oncol, 2019, 37(4_suppl):10. DOI: 10.1200/jco.2019.37.4_suppl.10.
|
[22] |
NEWMAN N K, MONNIER P M, RODRIGUES R R,et al. Host response to cholestyramine can be mediated by the gut microbiota[J]. bioRxiv, 2020. DOI: 10.1101/2020.12.08.416487.
|
[23] |
WANG T T, CAI G X, QIU Y P,et al. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers[J]. ISME J, 2012, 6(2):320-329. DOI: 10.1038/ismej.2011.109.
|
[24] |
ZHENG Y J, FANG Z Y, XUE Y,et al. Specific gut microbiome signature predicts the early-stage lung cancer[J]. Gut Microbes, 2020, 11(4):1030-1042. DOI: 10.1080/19490976.2020.1737487.
|
[25] |
IIDA N, DZUTSEV A, STEWART C A,et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment[J]. Science, 2013, 342(6161):967-970. DOI: 10.1126/science.1240527.
|
[26] |
|
[27] |
|